Bullish RSI BB SqueezeSKILLING:NASDAQ : SEEL Sqeeze Bollinger bands, volume on the daily. imminent stuffLongby GodtradesIwatch12
SeelosShort with tight stop if it reaches the arrowed line and does not close above it. This line will then become the stop. Take profit at the lower red lineShortby a1Keith0
Short SEEL NASDAQ:SEEL -EMA21 cross below EMA 50 -Price breached support level 1 -Price breached support level 2 -Radar: Possible pullback or continue down, watch for price to fall below SMA200.Shortby TacticalTradeUpdated 0
SEEL 519% upside according to this analyst SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to $4.00. 52 Week Range 0.76 - 6.60 Is this a strong buy? Looking forward to read your opinion about it. Longby TopgOptions115
Seelos Therapeutics Announces FDA Acceptance of Investigational SEEL: Seelos Therapeutics, Inc. 2021-11-08 08:00:00 Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar AtaxiaLongby RocketTickers3
SEEL BullishThe price tested the 200 sma and bounced. The current price is just bellow the POC (YTD). The divergence between the price and the MFI is a bullish signal. Like this set up for a long swing trade. Targeting: $4.29, $6.60 in the short-midterm. Longby Master_of_Fine_Charts112
20-150% Profits Possible on SEEL Therapeutics My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15. For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest). Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term. The stock market looks to continue its rally, with minor downs, as usual, until further notice. Biden's Infrastructure Plan may continue to stimulate the market to amazing new highs. I may invest in this on Monday. I really need to make some $$ for food, rent, and my beloved kitten. If it follows DLPN (Dolphin Entertainment), it may even beat its updated price target! DLPN was a rocket ship this year! Everyone go out and see some seals! News had it that the Great White Sharks of Cape Town have disappeared this year! Enough synchronicities, this is an ethical company that works on healing chronic diseases. Resources: stockinvest.us stocktwits.com finance.yahoo.com www.nasdaq.com seekingalpha.com investorshub.advfn.com seelostherapeutics.com #mayweallgetrichtogether Longby Grandmaster76Updated 3
SEELSEEL had an amazing day today, up 11%+! Confluence of 100% extension of AB from C and Supply make $8.50 a great target for this newly formed impulse.Longby Aperna3
Long on SEEL. View chart and like if you agreeTarget is 10 for this ascending triangle. Get ready, set... Like if you agree Longby mhasky6244110
Possible Breakout Buyer seems to be present in the tape. Good consolidation to the upside. Possible runner in the next couple of days. Longby amckee253
SEEL: Bullish Pennant (59%), Cup'n handle (92%)Primary Target: Bullish Pennant, confirmed (59%) PT = 6.71$ Secondary Target: Cup'n handle, awaiting confirmation (92%) PT = 8.26$Longby LeLaf3
SEEL 3/29/2021Daily Chart: Here I will look at the overall picture of this stock and identify what stage the market is in. This will determine whether I will be Long, Short, or staying out of the trade. The Picture is clear as day, we are currently in an Uptrend. After a lengthy Downtrend, the stock went into an Accumulation and broke out upwards on 12/21/2020. Price has since continued to move upwards in its Uptrend. It has also made several moves on its way up to show its growing strength. The price being above the 200 EMA confirms the Uptrend and the Golden Cross signaled the potential major rally. After the initial breakout and pullback, the price went on a very strong rally from 1.49 to 4.27 respecting the 10 EMA. The price ended up breaking down from the 10 EMA but bounced off the 50 EMA and rejected lower prices. This proved the Uptrend was still intact and the trend was still “healthy”. From there the Price made very strong move gaping the past 20 days and making 1-month highs. Following that move was a pullback and a price rejection of lower prices at the 10 EMA. This price rejection of the 10 EMA signals that the trend is once again very strong and we might be expecting a strong rally to higher prices. The Price is in an uptrend and a very strong one. I will be looking for an entry in the lower time frame to go LONG on this trade 1 HR chart: Here we can see the clear Support area at 4.15. Price has bounced off several times off this area but has also broken down below it and rejected the lower prices. The last rejection was a big one with the Buyers aggressively buying the lower prices and sending the price back above the 50ema and 4.15 Support area. Price has now pulled back to 4.15 area with back to back days of indecision candles at support. This is my que to enter. Entry: 4.30 Stop: Trailing 10ema on daily chart Longby rudcharts0
mid term +7,000%Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel technologies and therapeutics for the treatment of the central nervous system, respiratory, and other disorders. by SPIRITUAL7INTERELLECTUAL1
SEEL: Bullish Pennant (62%)Bullish Pennant (62%) Pros: Volume during post formation Descending volume during triangle formation PPS above 50MA and 200MA RS above 0 and ascending R/R ratio above 4 250RSI above 50 but flat 200MA ascending Cons: ATR Flat May fill gap back down to 3.15$ Target: PT = 6.96$ Help how ever you can to keep this alive. Thank you to those who have donated Coins! Always do your own due dilligence. This is not financial advice Stay Humble, have fun, make money! Education: www.dailyfx.com Longby LeLaf10
Textbook pullback playPulled back right to the .618 fib, consolidated then broke the triangle to flag to next fib up monitoring for continuation, targeting 8$ areaLongby StayPhr0sty3
BTIG buy recommendation with $14.00 price target- 360.5% upsideShares of $SEEL skyrocketed today after BTIG initiated coverage on the stock with a buy recommendation and a one-year price target nearly 4.7 times higher than Seelos' closing price on Thursday. BTIG analyst Robert Hazlett likes the prospects for Seelos' pipeline. Last week, the biotech announced that it had completed enrollment in a pivotal proof-of-concept study evaluating SLS-002 in treating acute suicidal ideation and behavior in patients with major depressive disorder. Seelos also has two other clinical-stage candidates. It's evaluating SLS-005 in phase 2 studies for three neurodegenerative disorders: amyotrophic lateral sclerosis (ALS), rare genetic disease Sanfilippo syndrome, and oculopharyngeal muscular dystrophy. Seelos should report key data from its study of SLS-002 in the second quarter of this year. Seelos also plans to advance SLS-005 into a pivotal phase 2b/3 clinical study targeting ALS in the first half of the year. www.fool.com seekingalpha.com by AlenCiken4
SEEL will rise againRetrace of rally to 68%. Sell volume went low. Forming an DOJI as sign of reversal.Longby PatrickShip1
SEEL (NASDAQ) - Moving in ChannelGreetings Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, do not be hesitant to send us message (inbox). Our Service : Signal recomendation, Trading Course, Portofolio Consultation for multi asset such as Stock, FX, Derivative, Crypto, etc. If u are newbie on the stock market, do not be hesitant to contact me at Private Message. Our Job is to make u Prof trader and proftable trader. Strategy - Please care for Money Management - Have a good psychology - Do not be hurry to open position - Evaluate and upgrade your trading plan SEEL (NASDAQ) - Moving in Channelby MultiAssetX3
$SEEL PT 90 and higherSeelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for the treatment of Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.Longby BADQOMOCAWGOWLD9
$SEEL Seelos Therapeutics Trade setup After hours mover on good volume. Stock was set up for a reversal . Potential trade between the daily resistance levels as per the chart . High risk and volatile stock. Longby Xclusive-Trading2220